Molecular detection of Zika virus in blood and RNA load determination during the French Polynesian outbreak

Journal of Medical Virology

Volumn 89, Issue 9, 2017, Pages 1505-1510

  Musso, Didier ^a   Rouault, Eline ^a   Teissier, Anita ^a   Lanteri, Marion C ^b,c   Zisou, Karen ^a   Broult, Julien ^d   Grange, Emilie ^a   Nhan, Tu Xuan ^a   Aubry, Maite ^a  

^a INSTITUT LOUIS MALARDÉ   (French Polynesia)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Centre de Transfusion Sanguine   (French Polynesia)

Author keywords

arbovirus; French Polynesia; RNA load; RT PCR; Zika virus

Indexed keywords

ADULT; ARTHRALGIA; ARTICLE; ASTHENIA; CLINICAL FEATURE; CONJUNCTIVITIS; CONTROLLED STUDY; CROSS REACTION; DISEASE SEVERITY; FEMALE; FEVER; FRENCH POLYNESIAN; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; MOLECULAR DYNAMICS; MYALGIA; NONHUMAN; RASH; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SYNTHESIS; VIRUS LOAD; ZIKA FEVER; ZIKA VIRUS; ADOLESCENT; AGED; BLOOD; CHILD; EPIDEMIC; GENETICS; INFANT; ISOLATION AND PURIFICATION; MIDDLE AGED; NEWBORN; PATHOLOGY; POLYNESIA; PRESCHOOL CHILD; TIME FACTOR; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

VIRUS RNA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; POLYNESIA; RNA, VIRAL; TIME FACTORS; VIRAL LOAD; YOUNG ADULT; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85024132534     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24735     Document Type: Article

References (50)

1. Gubler DJ, Kuno G, Markoff L. Flaviviruses. Field Virology. 5th ed. Philadelphia, USA: Lippincott Williams & Wilkins; 2007; 34:1155–1227.
2. Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Tropl Med Hyg 1952; 46:509–520.
3. Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, Pretrick M, Marfel M, Holzbauer S, Dubray C, Guillaumot L, Griggs A, Bel M, Lambert AJ, Laven J, Kosoy O, Panella A, Biggerstaff BJ, Fischer M, Hayes EB. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009; 360:2536–2543.
4. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, Stanfield SM, Duffy MR. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008; 14:1232–1239.
5. Cao-Lormeau VM, Roche C, Teissier A, Robin E, Berry AL, Mallet HP, Sall AA, Musso D. Zika virus, French Polynesia, South Pacific, 2013. Emerg Infect Dis 2014; 20:1085–1086.
6. Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect 2014; 20:O595–O596.
7. Musso D, Gubler DJ. Zika virus. Clin Microbiol Rev 2016; 29:487–524.
8. World Health Organization (WHO). 2016; Situation report Zika virus Microcephaly Guillain-Barré syndrome 15 September 2016. http://apps.who.int/iris/bitstream/10665/250122/1/zikasitrep15Sep16-eng.pdf?ua=1
9. Center for disease control and prevention (CDC). 2016;ZIKV Florida. http://www.cdc.gov/media/releases/2016/p0729-florida-zika-cases.html
10. Dyer O. Outbreak of Zika in Singapore sparks warnings in neighbouring countries. BMJ 2016; 354:i4740.
11. D'Ortenzio E, Matheron S, de Lamballerie X, Hubert B, Piorkowski G, Maquart M, Descamps D, Damond F, Leparc-Goffart I. Evidence of sexual transmission of Zika virus. N Engl J Med 2016; 374:2195–2198.
12. Hills SL, Russell K, Hennessey M, Williams C, Oster AM, Fischer M, Mead P. Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission—continental United States, 2016. MMWR Morb Mortal Wkly Rep 2016; 65:215–216.
13. Musso D, Roche C, Robin E, Nhan T, Teissier A, Cao-Lormeau VM. Potential sexual transmission of Zika virus. Emerg Infect Dis 2015; 21:359–361.
14. Besnard M, Lastère S, Teissier A, Cao-Lormeau V, Musso D. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill 2014; 19:pii:20751.
15. Mlakar J, Korva M, Tul N, Popović M, Poljšak-Prijatelj M, Mraz J, Kolenc M, Resman Rus K, Vesnaver Vipotnik T, Fabjan Vodušek V, Vizjak A, Pižem J, Petrovec M, Avšič Županc T. Zika virus associated with microcephaly. New Engl J Med 2016; 374:951–958.
16. Food and Drug Administration (FDA). 2016; Recommendations for donor screening, deferral, and product management to reduce the risk of transfusion-transmission of Zika virus. http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM486360.pdf
17. Musso D, Stramer SL, Bush MP. Zika virus: a new challenge for blood transfusion. Lancet 2016; 387:1993–1994.
18. Bonaldo MC, Ribeiro IP, Lima NS, Dos Santos AA, Menezes LS, da Cruz SO, de Mello IS, Furtado ND, de Moura EE, Damasceno L, da Silva KA, de Castro MG, Gerber AL, de Almeida LG, Lourenço-de-Oliveira R, Vasconcelos AT, Brasil P. Isolation of infective Zika virus from urine and saliva of patients in Brazil. PLoS Negl Trop Dis 2016; 10:e0004816.
19. Zhang FC, Li XF, Deng YQ, Tong YG, Qin CF. Excretion of infectious Zika virus in urine. Lancet Infect Dis 2016; 16:641–642.
20. Dupont-Rouzeyrol M, Biron A, O'Connor O, Huguon E, Descloux E. Infectious Zika viral particles in breastmilk. Lancet 2016; 387:1051.
21. Mallet HP, Vial AL, Musso D. Bilan de l’épidémie à virus Zika en Polynésie française, 2013–2014. French Polynesia outbreak of Zika in French Polynesia, 2013–2014. BISE 2015; 13:1–5.
22. Bel M. 2007; Zika virus Information for clinician and other health professionals. Yap State Department of Health Services. http://www.spc.int/phs/english/publications/informaction/IA27/Zika-outbreak-Yap-2.pdf
23. Brasil P, Calvet GA, Siqueira AM, Wakimoto M, de Sequeira PC, Nobre A, Quintana Mde S, Mendonça MC, Lupi O, de Souza RV, Romero C, Zogbi H, Bressan Cda S, Alves SS, Lourenço-de-Oliveira R, Nogueira RM, Carvalho MS, de Filippis AM, Jaenisch T. Zika virus outbreak in Rio de Janeiro, Brazil: clinical characterization, epidemiological and virological aspects. PLoS Negl Trop Dis 2016; 10:e0004636.
24. World Health Organization (WHO). 2016; Laboratory testing for Zika virus infection. Interim guidance 23 March 2016. http://apps.who.int/iris/bitstream/10665/204671/1/WHO_ZIKV_LAB_16.1_eng.pdf?ua=1
25. Centers for Disease Control and Prevention (CDC). 2016; Guidance for U.S. Laboratories testing for Zika virus infection, June 26 2016. http://www.cdc.gov/zika/pdfs/laboratory-guidance-zika.pdf
26. Aubry M, Finke J, Teissier A, Roche C, Broult J, Paulous S, Desprès P, Cao-Lormeau VM, Musso D. Seroprevalence of arboviruses among blood donors in French Polynesia, 2011–2013. Int J Infect Dis 2015; 41:11–12.
27. Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika virus. N Engl J Med 2016; 374:1552–1563.
28. Aubry M, Richard V, Green J, Broult J, Musso D. Inactivation of Zika virus in plasma with amotosalen and ultraviolet A illumination. Transfusion 2015; 56:33–40.
29. Musso D, Nhan T, Robin E, Roche C, Bierlaire D, Zisou K, Shan Yan A, Cao-Lormeau VM, Broult J. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill 2014; 19:pii:20771.
30. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992; 30:545–551.
31. Musso D, Roche C, Nhan TX, Robin E, Teissier A, Cao-Lormeau VM. Detection of Zika virus in saliva. J Clin Virol 2015; 68:53–55.
32. Binguam AM, Cone M, Mock V, Heberlein-Larson L, Stanek D, Blackmore C, Likos A. Interim guidance for Zika virus testing of urine—United States, 2016. MMWR 2016; 65:474.
33. Waterman S, Gubler DJ. Dengue fever. Clin Dermatol 1989; 7:117–122.
34. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11:480–496.
35. Chen LH, Wilson ME. Non-vector transmission of dengue and other mosquito-borne flaviviruses. WHO Dengue Bull 2005; 29:18–31.
36. Barzon L, Pacenti M, Berto A, Sinigaglia A, Franchin E, Lavezzo E, Brugnaro P, Palù G. Isolation of infectious Zika virus from saliva and prolonged viral RNA shedding in a traveller returning from the Dominican Republic to Italy, January 2016. Euro Surveill 2016; 21: DOI: 10.2807/1560-7917.ES.2016.21.10.30159
37. Driggers RW, Ho CY, Korhonen EM, Kuivanen S, Jääskeläinen AJ, Smura T, Rosenberg A, Hill DA, DeBiasi RL, Vezina G, Timofeev J, Rodriguez FJ, Levanov L, Razak J, Iyengar P, Hennenfent A, Kennedy R, Lanciotti R, du Plessis A, Vapalahti O. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med 2016; 374:2142–2151.
38. Wæhre T, Maagard A, Tappe D, Cadar D, Schmidt-Chanasit J. Zika virus infection after travel to Tahiti, December 2013. Emerg Infect Dis 2014; 20:1412–1414.
39. Mansuy JM, Dutertre M, Mengelle C, Fourcade C, Marchou B, Delobel P, Izopet J, Martin-Blondel G. Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen? Lancet Infect Dis 2016; 16:894–895.
40. Waggoner JJ, Gresh L, Vargas MJ, Ballesteros G, Tellez Y, Soda KJ, Sahoo MK, Nuñez A, Balmaseda A, Harris E, Pinsky BA. Viremia and clinical presentation in Nicaraguan patients infected with Zika virus, chikungunya virus, and dengue virus. Clin Infect Dis 2016; pii:ciw589.
41. Appassakij H, Khuntikij P, Kemapunmanus M, Wutthanarungsan R, Silpapojakul K. Viremic profiles in asymptomatic and symptomatic chikungunya fever: a blood transfusion threat? Transfusion 2013; 53:2567–2574.
42. Zou S, Foster GA, Dodd RY, Petersen LR, Stramer SL. West Nile fever characteristics among viremic persons identified through blood donor screening. J Infect Dis 2010; 202:1354–1361.
43. Lanteri MC, Lee T-H, Wen L, Kaidarova Z, Bravo MD, Kiely NE, Kamel HT, Tobler LH, Norris PJ, Busch MP. West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety. Transfusion 2014; 54:3232–3241.
44. Murgue B, Roche C, Chungue E, Deparis X. Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia. J Med Virol 2000; 60:432–438.
45. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181:2–9.
46. Wang W-K, Chao D-Y, Kao C-L, Wu H-C, Liu Y-C, Li C-M, Lin S-C, Ho S-T, Huang J-H, King C-C. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology 2003; 305:330–338.
47. Fox A, Le NM, Simmons CP, Wolbers M, Wertheim HF, Pham TK, Tran TH, Trinh TM, Nguyen TL, Nguyen VT, Nguyen DH, Farrar J, Horby P, Taylor WR, Nguyen VK. Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam. PLoS Negl Trop Dis 2011; 5:e967.
48. Sudiro TM, Zivny J, Ishiko H, Green S, Vaughn DW, Kalayanarooj S, Nisalak A, Norman JE, Ennis FA, Rothman AL. Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. J Med Virol 2001; 63:29–34.
49. Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 2009; 22:564–581.
50. Gourinat AC, O'Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol M. Detection of Zika virus in urine. Emerg Infect Dis 2015; 21:84–86.